| Urinary soluble CD163 in active renal vasculitis VP O’Reilly, L Wong, C Kennedy, LA Elliot, S O’Meachair, AM Coughlan, ... Journal of the American Society of Nephrology 27 (9), 2906-2916, 2016 | 129 | 2016 |
| Peptide length significantly influences in vitro affinity for MHC class II molecules C O'Brien, DR Flower, C Feighery Immunome research 4, 1-7, 2008 | 100 | 2008 |
| Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology Platform Lungscape Project I Letovanec, S Finn, P Zygoura, P Smyth, A Soltermann, L Bubendorf, ... Journal of Thoracic Oncology 13 (3), 413-425, 2018 | 77 | 2018 |
| RET fluorescence in situ hybridization analysis is a sensitive but highly unspecific screening method for RET fusions in lung cancer T Radonic, WRR Geurts-Giele, KG Samsom, GMJM Roemen, ... Journal of Thoracic Oncology 16 (5), 798-806, 2021 | 35 | 2021 |
| Molecular testing in oncology: problems, pitfalls and progress CP O’Brien, SE Taylor, JJ O’Leary, SP Finn Lung Cancer 83 (3), 309-315, 2014 | 28 | 2014 |
| Deep learning of histopathological features for the prediction of tumour molecular genetics P Murchan, C Ó’Brien, S O’Connell, CS McNevin, AM Baird, O Sheils, ... Diagnostics 11 (8), 1406, 2021 | 25 | 2021 |
| Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience N Osman, YY Elamin, S Rafee, C O’Brien, LFA Stassen, C Timon, ... European archives of oto-rhino-laryngology 271, 2253-2259, 2014 | 25 | 2014 |
| High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients K van den Hurk, B Balint, S Toomey, PC O’Leary, L Unwin, K Sheahan, ... Melanoma Research 25 (3), 189-199, 2015 | 17 | 2015 |
| Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy SA O’Toole, C Spillane, Y Huang, MC Fitzgerald, B Ffrench, B Mohamed, ... Breast Cancer Research and Treatment 181, 571-580, 2020 | 15 | 2020 |
| Cost-efficient and easy to perform PCR-based assay to identify met exon 14 skipping in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) samples O O’Brien, MC Wright, C O’Brien, O Geoghegan, N Leonard, S Nicholson, ... Diagnostics 9 (1), 13, 2019 | 15 | 2019 |
| Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative … T Frawley, CP O'Brien, E Conneally, E Vandenberghe, M Percy, ... Genetic Testing and Molecular Biomarkers 22 (2), 98-103, 2018 | 7 | 2018 |
| Session 2: Personalised nutrition Transcriptomic signatures that have identified key features of metabolic syndrome: Symposium on ‘The challenge of translating nutrition … MJ Morine, C O'Brien, HM Roche Proceedings of the Nutrition Society 67 (4), 395-403, 2008 | 7 | 2008 |
| Epidermal growth factor receptor (EGFR) mutation testing, from bench to practice: a single institute experience H Shikhrakab, YY Elamin, C O'Brien, K Gately, S Finn, K O'Byrne, ... Ir Med J 107 (7), 201-4, 2014 | 4 | 2014 |
| Predictive values for molecular diagnostics: converting unknown unknowns to known unknowns CP O’Brien, SE Langabeer, KJ O’Byrne, JJ O’Leary, SP Finn Molecular diagnosis & therapy 18, 1-4, 2014 | 3 | 2014 |
| CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity B Ffrench, E Kashdan, Y Huang, CD Spillane, S Cocchiglia, S Charmsaz, ... Heliyon 9 (1), 2023 | 2 | 2023 |
| Molecular subtyping of diffuse large B-cell lymphoma using a novel quantitative RT-PCR assay R Ta, C Santini, P Gou, G Lee, YC Tai, C O’Brien, M Fontecha, C Grant, ... The Journal of Molecular Diagnostics 23 (3), 323-340, 2021 | 2 | 2021 |
| Co-occurrence of EGFR sensitising and resistance mutations at diagnosis in NSCLC D Kelly, L Burke, C O’Brien, R Kearns, S Rafee, D Power, S O’Reilly, ... Irish Journal of Medical Science (1971-) 188, 405-408, 2019 | 1 | 2019 |
| P3. 02-053 optimization and characterization of assays to identify met exon 14 skipping in FFPE embedded NSCLC samples S Gray, O O’Brien, C O'Brien, M Wright, O Geoghegan, N Leonard, ... Journal of Thoracic Oncology 12 (11), S2256-S2257, 2017 | 1 | 2017 |
| Genomic Landscape of NSCLC in the Republic of Ireland RJ Keogh, MP Barr, A Keogh, D McMahon, C O’Brien, SP Finn, J Naidoo JTO Clinical and Research Reports 5 (2), 100627, 2024 | | 2024 |
| EP06. 03-19 Genomic Landscape of Non-Small Cell Lung Cancer in the Republic of Ireland RJ Keogh, MP Barr, A Keogh, D Mc Mahon, C O'Brien, SP Finn, J Naidoo Journal of Thoracic Oncology 18 (11), S490-S491, 2023 | | 2023 |
